Browsing Tag
Chinese biotech
3 posts
Pollon Life files for Hong Kong IPO: Is Jack Ma’s stem cell bet about to pay off?
Find out how Pollon Life, backed by Jack Ma’s Yunfeng Capital, is planning a Hong Kong IPO and what it signals for China’s biotech revival.
Kelun-Biotech reports strong Phase 3 data for sacituzumab tirumotecan in HR+/HER2- breast cancer
Kelun-Biotech’s sacituzumab tirumotecan doubled PFS in HR+/HER2- breast cancer. Find out what this means for patients, investors, and China’s ADC landscape.
BioCity’s SC0062 secures second breakthrough therapy designation in China for diabetic kidney disease
BioCity Biopharma’s ETA-selective SC0062 earns second Breakthrough Therapy Designation in China for diabetic kidney disease, reinforcing its CKD potential.